title: Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis.
abstract: BACKGROUND
  The incidence of death among patients admitted for severe sepsis or septic shock is high. Adrenomedullin (ADM) plays a central role in initiating the hyperdynamic response during the early stages of sepsis. Pilot studies indicate an association of plasma ADM with the severity of the disease. In the present study we utilized a novel sandwich immunoassay of bioactive plasma ADM in patients hospitalized with sepsis in order to assess the clinical utility.
  
  
  METHODS
  We enrolled 101 consecutive patients admitted to the emergency department with suspected sepsis in this study. Sepsis was defined by fulfillment of at least two systemic inflammatory response syndrome (SIRS) criteria plus clinical suspicion of infection. Plasma samples for ADM measurement were obtained on admission and for the next four days. The 28-day mortality rate was recorded.
  
  
  RESULTS
  ADM at admission was associated with severity of disease (correlation with Acute Physiology and Chronic Health Evaluation II (APACHE II) score: r = 0.46; P <0.0001). ADM was also associated with 28-day mortality (ADM median (IQR): survivors: 50 (31 to 77) pg/mL; non-survivors: 84 (48 to 232) pg/mL; P <0.001) and was independent from and additive to APACHE II (P = 0.02). Cox regression analysis revealed an additive value of serial measurement of ADM over baseline assessment for prediction of 28-day mortality (P < 0.01). ADM was negatively correlated with mean arterial pressure (r = -0.39; P <0.0001), and it strongly discriminated those patients requiring vasopressor therapy from the others (ADM median (IQR): no vasopressors 48 (32 to 75) pg/mL; with vasopressors 129 (83 to 264) pg/mL, P <0.0001).
  
  
  CONCLUSIONS
  In patients admitted with sepsis, severe sepsis or septic shock plasma ADM is strongly associated with severity of disease, vasopressor requirement and 28-day mortality.
authors.forename: Rossella
authors.initials: R
authors.lastname: Marino
authors.forename: Joachim
authors.initials: J
authors.lastname: Struck
authors.forename: Alan S
authors.initials: AS
authors.lastname: Maisel
authors.forename: Laura
authors.initials: L
authors.lastname: Magrini
authors.forename: Andreas
authors.initials: A
authors.lastname: Bergmann
authors.forename: Salvatore
authors.initials: S
authors.lastname: Di Somma
mesh_terms: D018806:APACHE; D053607:Adrenomedullin / Q000097:blood*; D000328:Adult; D000368:Aged; D004636:Emergency Service, Hospital; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D018805:Sepsis / Q000097:blood* / Q000401:mortality / Q000628:therapy; D012720:Severity of Illness Index; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
chemical_list: D014662:Vasoconstrictor Agents; D053607:Adrenomedullin